Morgan Stanley Neuro Pace Inc Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NPCE
# of Institutions
57Shares Held
19.8MCall Options Held
28.3KPut Options Held
300-
Kck Ltd. Tortola, D85.62MShares$35.9 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$21.7 Million0.62% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$15.5 Million1.86% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.14MShares$7.3 Million3.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA968KShares$6.17 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $159M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...